0 XP   0   0   0

Regeneron Pharmaceuticals Inc - Trending symbols

Notifications

TypeNotificationDate
RSI OversoldOversold RSI (Relative Strength Index)2024-04-27



Trends

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Tax Provision 127,600-87,40040,20074,300114,500-11,500103,000-115,000-12,000
Income Tax Expense 127,600-87,40040,20074,300114,500-11,500103,000-115,000-12,000
Other Stockholders Equity -404,000-43,800-447,800-429,600-877,400-142,200-1,019,60031,531,30030,511,700
Net Interest Income -15,300-2,100-17,400-600-18,000-900-18,900134,800115,900
Interest Expense 13,600-50013,1002,20015,3002,10017,400-35,400-18,000
Net non Operating Income Other -16,400-105,800-122,200-61,600-183,80050,200-133,600435,000301,400
Total Other Income Expense Net -30,600-105,700-136,300-61,100-197,40050,700-146,700432,800286,100
Long-term Assets Other 145,90076,900222,80039,200262,0007,900269,900-6,238,500-5,968,600
Other Current Assets 213,600230,700444,30037,700482,000-149,600332,400-14,467,000-14,134,600
Accumulated Other Comprehensive Income 29,300-13,10016,200-50015,700-6,2009,500-35,700-26,200

Comments

How you think about this?

Leave a comment

Stay informed about Regeneron Pharmaceuticals Inc.

Receive notifications about Regeneron Pharmaceuticals Inc in your mailbox!